Colorectal Carcinoma Clinical Trials in Los Angeles, California
9 recruitingLos Angeles, California
Showing 1–9 of 9 trials
Recruiting
Phase 1
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Endometrial CancerColorectal CarcinomaNon-small Cell Lung Cancer+3 more
AstraZeneca108 enrolled18 locationsNCT06218914
Recruiting
Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast Carcinoma+37 more
National Cancer Institute (NCI)51 enrolled23 locationsNCT04704661
Recruiting
Phase 1
A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas
Colorectal CarcinomaGastric CarcinomaPancreatic Ductal Adenocarcinoma
Boehringer Ingelheim135 enrolled3 locationsNCT06882746
Recruiting
Phase 1Phase 2
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Ovarian CarcinomaColorectal CarcinomaMelanoma+19 more
Children's Oncology Group147 enrolled21 locationsNCT04851119
Recruiting
Not Applicable
A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers
Colorectal Carcinoma
Jonsson Comprehensive Cancer Center1,500 enrolled2 locationsNCT06568016
Recruiting
Not Applicable
CoGENES Randomized Controlled Trial (RCT)
Colorectal Carcinoma
University of Southern California140 enrolled1 locationNCT07229443
Recruiting
Not Applicable
Confronting Cancer as a Community
Colorectal Carcinoma
University of Southern California500 enrolled2 locationsNCT06063928
Recruiting
Not Applicable
Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
Colorectal Carcinoma
Jonsson Comprehensive Cancer Center1,680 enrolled1 locationNCT06376565
Recruiting
Phase 1
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Breast CarcinomaUrothelial CarcinomaOvarian Carcinoma+31 more
Jonsson Comprehensive Cancer Center30 enrolled1 locationNCT07118176